Insilico Medicine and Bora Pharmaceuticals announced a multi-target strategic alliance pairing Insilico’s generative AI discovery capabilities with Bora’s global pharmaceutical manufacturing operations. The agreement is structured around definitive governance and execution terms, aimed at supporting end-to-end development for AI-discovered candidates through manufacturing capacity and process execution.